spersadex comp eye drops
laboratoires thea 12 rue louis blériot, 63017 clermont-ferrand cedex 2, france - dexamethasone sodium, phosphate, chloramphenicol - eye drops, solution - dexamethasone sodium phosphate 1 mg/ml chloramphenicol 5 mg/ml - ophthalmologicals
shinadex eye drops
y.s.p. industries (m) sdn bhd - chloramphenicol; dexamethasone sodium phosphate -
tarocidin d
taro pharmaceutical industries ltd - chloramphenicol; dexamethasone sodium phosphate; polymyxin b sulfate - eye drops - chloramphenicol 2 mg/ml; dexamethasone sodium phosphate 0.25 mg/ml; polymyxin b sulfate 2500 u/ml - dexamethasone and antiinfectives - dexamethasone and antiinfectives - for the treatment of serious superficial ocular infections due to strains of microorganisms susceptible to chloramphenicol and/or polymyxin b sulphate.
de icol 4 mg/ml - 1 mg/ml eye drops sol.
viatris healthcare sa-nv - chloramphenicol 0,4 g/100 ml; dexamethasone sodium phosphate 0,1 g/100 ml - eye drops, solution - 4 mg/ml - 1 mg/ml - dexamethasone sodium phosphate 1 mg/g; chloramphenicol 4 mg/g - dexamethasone and antiinfectives
spersadex comp. eye drops
adcock ingram ltd - dexamethasone disodium phosphate, chloramphenicol, hydroxypropylmethylcellulose, - eye drops - dexamethasone disodium phosphate 0.1g, chloramphenicol 0.5g, hydroxypropylmethylcellulo-se 0. 2g,sterile water qs to 100ml
spersadexoline eye drops
adcock ingram ltd - dexamethasone disodium phosphate, chloramphenicol, hydroxypropylmethylcellulose, - eye drops - dexamethasone disodium phosphate 0.1g, chloramphenicol 0.5g, hydroxypropylmethylcellulo-se 0. 2g,sterile water qs to 100ml
chloramphenicol sodium succinate- chloramphenicol sodium succinate injection, powder, lyophilized, for solution
fresenius kabi usa, llc - chloramphenicol sodium succinate (unii: 872109hx6b) (chloramphenicol - unii:66974fr9q1) - chloramphenicol 1 g in 10 ml - in accord with the concepts in the warning box and this indications and usage section, chloramphenicol must be used only in those serious infections for which less potentially dangerous drugs are ineffective or contraindicated. however, chloramphenicol may be chosen to initiate antibiotic therapy on the clinical impression that one of the conditions below is believed to be present; in vitro sensitivity tests should be performed concurrently so that the drug may be discontinued as soon as possible if less potentially dangerous agents are indicated by such tests. the decision to continue use of chloramphenicol rather than another antibiotic when both are suggested by in vitro studies to be effective against a specific pathogen should be based upon severity of the infection, susceptibility of the pathogen to the various antimicrobial drugs, efficacy of the various drugs in the infection, and the important additional conce
pharmadexnicol eye drops
dexamethasone sodium phosphate and chloramphenicol - eye drops - 0.1% w/v dexamethasone phosphate and 1% w/v - dexamethasone and antiinfectives
aurocol-dm 5mg + 1mg solution, ophthalmic
brady pharma inc - chloramphenicol , dexamethasone sodium phosphate - solution, ophthalmic - 5mg + 1mg
ipecor 5mg/ 1mg per ml ophthalmic solution
medilife pharma, inc, - chloramphenicol , dexamethasone sodium phosphate - ophthalmic solution - 5mg/ 1mg per ml